Join Lonza's experts for a number of scientific program presentations, rapid-fires and posters at AAPS! During these sessions, learn more about our capabilities in drug product, particle engineered intermediates and drug substance.

PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a small niche meeting. It features six tracks, five of which are split equally between chemical and biomolecule drug programming. These tracks encompass many areas making the biggest headlines today. Learn more about the event here.
 
 
We hope you can join us for the following technical sessions virtually. Mark your calendar!
 

Scientific Program Presentations

 

Join us for the following two hour scientific program sessions composed of four, themed, 30 minute presentations.

 

  
Hanns-Christian Mahler
 
 
Hanns-Christian Mahler, Ph.D.
Head Drug Product Services, Lonza
  
Deanna Mudie
 
 
Deanna Mudie, Ph.D. 
Principal Scientist, Global Research and Development, Lonza
  
Ahmed Besheer
 
 
Ahmed Besheer, Ph.D.
Head Formulation Development, Lonza
Track: Formulation and Delivery – Biomolecular
 
Track: Formulation and Delivery – Chemical
 
Track: Formulation and Delivery – Biomolecular
 

Prologue: Formulation development challenges of emerging modalities
Tuesday, November 3, 2020 9:30 AM – 10:00 AM EST
 
Symposium: Formulation development challenges for emerging modalities
Tuesday, November 3, 2020 10:30 AM – 12:30 PM EST 
 

A novel architecture for high drug-loaded amorphous solid dispersion tablets; assessment of in vitro and in vivo performance, stability and manufacturability
Wednesday, October 28, 2020, 11:00 AM - 11:30 AM EST

Strategies in formulation development of novel biologics modalities
Tuesday, November 3, 2020 11:00 AM – 11:30 AM EST


 

 Rapid-Fire Presentations

 

Join us for the following 10 minute rapid-fire presentations presenting novel and exciting research and ideas for the industry.

 



  



Kimberley

  
Andreas Zerr, BS
Lead Scientist
  
Jenifer Mains, Ph.D.
Senior Manager Formulation

Joachim Schuster, Ph.D. candidate
Assoc. Principal Scientist
  

Jonathan Cape, Ph.D.
Principal Scientist
  
Kimberly Shepard, Ph.D.
Associate Principal Engineer
  
Michael Jahn, Ph.D. 
Head Forensic Chemistry
  

Measuring lipolytic activity in biologics drug substance and drug product

Tuesday, November 3, 2020 9:45 AM – 10:00 AM EST

Processing low viscosity products using liquid filling and banding technology

Thursday, October 29, 2020 3:30 PM – 3:45 PM EST

In vivo protein stability - what happens after administration?

Monday, November 2, 3:45 PM – 4:00 PM EST

Modeling phase separation risk during spray drying from mixed solvents

Thursday, October 29, 2020 3:30 PM – 3:45 PM EST

Methanol-assisted secondary drying to accelerate residual-solvent removal in spray-dried polymers

Tuesday, October 27, 2020 4:00 PM – 4:15 PM EST

Polysorbate in biologics – understanding degradation by applying proper analytics

Monday, November 2, 2020 4:15 PM – 4:30 PM EST


   

Poster Presentations

 




  • A hierarchical mass transfer model for drug particle dissolution in collaboration with the University of Michigan, co-authored by Deanna Mudie Deanna Mudie, Ph.D., Principal Scientist, Global Research and Development
  • Application of Colorista® capsules for rapid product development with proof of concept data for a heat, oxygen, and moisture sensitive compound presented by Namrata Vora, M.S., Research Scientist III, Product Development
  • Encapsulating low viscosity products using liquid filling and banding technology presented by Jenifer Mains, Senior Group Leader
  • Impact of uneven illumination in flow imaging flow cell on the sizing accuracy of beads and implication for biopharmaceutical drug products presented by Ahmad Sediq, Ph.D., Principal Scientist, Formulation Development
  • In vivo stability of therapeutic proteins presented by Joachim Schuster, Ph.D. Candidate, Assoc. Principal Scientist
  • Methanol-assisted secondary drying to accelerate residual solvent removal in spray-dried polymers presented by Kimberly Shepard, Ph.D., Associate Principal Engineer
  • Modeling the impact of amorphous drug-polymer colloids on the absorption of poorly water soluble drugs presented by Aaron Stewart, M.S., Associate Principal Scientist
  • Particle identification and source analysis presented by Michael Jahn, Ph.D., Senior Principal Scientist, Forensic Chemistry 
  • Stabilizing polysorbate 20 and 80 against oxidative degradation presented by Ariane Schmidt, Ph.D. Candidate, Drug Product Services
  • Subvisible particles in intravenous infusion bags presented by Maximilian Wozniewski, Ph.D. Candidate, Scientist
 

 

Meet 1-2-1 with our expert in he virtual event: schedule a session.

 
 

 
  Can’t attend the virtual event? Access other relevant technical content in our Knowledge Center:
  • 2019 AAPS PharmSci 360 presented posters, see now
  • On-demand webinar "Specialized clinical services for complex clinical studies", watch now
  • On-demand webinar "Navigating CMC Regulatory requirements for accelerated commercialization", watch now
  • On-demand webinar "Solid form screening and its role in drug development", watch now
  • Live webinar "Applying visual techniques to the product design of lipid multiparticulates", register now
  • Live webinar "Liquid-filled hard capsules: A flexible tool for rapid access to the clinic with poorly soluble and/or highly potent compounds", register now
   


  
 

Lorem ipsum dolor sit amet